CESC Q2 net up at Rs 195 cr

CESC Ltd today posted 1.5 per cent rise in net profit at Rs 195 crore for the quarter ended September 30.
The company, engaged in generation and distribution of electricity, had reported a net profit after tax of Rs 192 crore in the year-ago period, CESC said in a filing to BSE.
The total income of CESC during the quarter was at Rs 1,797 crore, registering an increase of 7.09 per cent.
Its total income in the corresponding quarter of the last fiscal was Rs 1,678 crore.
**************
RattanIndia Power Q2 net loss narrows to Rs 125.52 cr

RattanIndia Power Ltd's net loss for the second quarter ended September 30 narrowed to Rs 125.52 crore on account of higher income.

The company had reported a net loss of Rs 158.41 crore in the corresponding quarter of the previous year.
Total revenue of the company jumped over three-fold to Rs 702.12 crore compared with total income of Rs 199.7 crore in the corresponding period a year ago.
RattanIndia Power shares closed 2.42 per cent up at Rs 8.05 apiece on the BSE.
***************
Vivimed Labs Q2 net up 45% at Rs 24 cr
Vivimed Labs Ltd today reported a 45.46 per cent increase in net profit at Rs 23.87 crore in the second quarter ended September 30.
The company had reported a net profit of Rs 16.41 crore in the corresponding quarter of the previous year.

Total income from operations of the Hyderabad-based company increased to Rs 337.02 crore, up 7.45 per cent, as against Rs 313.63 crore in the corresponding period a year ago.
Vivimed Labs' shares closed at Rs 371.50 apiece on the BSE, up 0.95 per cent.
**************
Natco Pharma Q2 dips 9% to Rs 29.57 cr
Natco Pharma today reported a 8.64 per cent dip in consolidated net profit to Rs 29.57 crore for the September quarter of 2015-16 fiscal.
The company had posted a net profit of Rs 32.37 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.

The consolidated total income from operations, however, rose to Rs 234.90 core in the quarter under review as against Rs 219.23 crore during the same period a year ago.
Shares of Natco Pharma closed at Rs 2,458 per scrip, down 0.13 per cent on BSE.